Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Hepatology

• Publication date

  2000-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/jhep.2000.9603PMID 10915729
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences in estrogen receptor alpha variant messenger RNAs between normal human breast tissue and primary breast carcinomas.

  2000cited by this paper
• The natural history of hepatocellular carcinoma in Western countries.

  1998cited by this paper
• Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients.

  1998cited by this paper
• Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease

  1998cited by this paper
• Prognosis of hepatocellular carcinoma patients with extrahepatic metastases.

  1997cited by this paper
• Type of estrogen receptor determines response to antiestrogen therapy.

  1996cited by this paper
• Multiple splicing variants of the estrogen receptor are present in individual human breast tumors.

  1996cited by this paper
• Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

  1996cited by this paper
• Des‐γ‐carboxy prothrombin and α‐fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma

  1996cited by this paper
• Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.

  1996cited by this paper
• Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma.

  1995cited by this paper
• Growth patterns and interstitial invasion of small hepatocellular carcinoma

  1995cited by this paper
• Estrogen receptor mutagenesis and hormone resistance

  1994cited by this paper
• Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection

  1993cited by this paper
• Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors.

  1992cited by this paper
• Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

  1992cited by this paper
• Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival

  1992cited by this paper
• Hepatocellular carcinoma in Italian patients with cirrhosis.

  1991cited by this paper
• Tumor size determines the long-term efficacy of percutaneous ethanol injection (PEI) for the treatment of hepatocellular carcinoma (HCC)

  1991cited by this paper
• Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases.

  1990cited by this paper
• Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population.

  1990cited by this paper
• Risk factors for hepatocellular carcinoma in italy. Male sex, hepatitis b virus, non‐a non‐B infection, and alcohol

  1988cited by this paper
• Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients.

  1986cited by this paper
• Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications.

  1985cited by this paper
• Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients.

  1985cited by this paper
• Prognosis of Primary Hepatocellular Carcinoma

  1984cited by this paper
• Letter: Osteoporosis and androgens.

  1976cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Observations on growth rates of human tumors.

  1956cited by this paper

• Impacts of Liver Resection with Neoadjuvant Treatment Versus Surgery Alone in Hepatocellular Carcinoma with Portal Vein Tumour Thrombosis: A Systematic Review and Meta-Analysis

  2026cites this paper
• The potential efficacy of atezolizumab plus bevacizumab treatment for hepatocellular carcinoma patients with macroscopic portal vein tumor thrombus

  2025cites this paper
• Demographic and survival characteristics of untreated hepatocellular carcinoma patients: insights into the natural history and prognostic determinants.

  2025cites this paper
• Steroid receptors and coregulators: Dissemination of sex differences and emerging technologies

  2025influential citation
• Deciphering the pharmacological mechanisms of Scutellariae Radix on hepatocellular carcinoma by combining network pharmacology, metabolomics and experimental evaluations.

  2025cites this paper
• Oral contraceptive use and risk of liver cancer: a population-based study, systematic review, and meta-analysis

  2025cites this paper
• Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis

  2024cites this paper
• Multidisciplinary treatment for patients with advanced hepatocellular carcinoma complicated by Vp4 portal vein tumor thrombosis: Combination of atezolizumab and bevacizumab after hepatic arterial infusion chemotherapy and radiotherapy: A case series

  2024cites this paper
• Hepatic infarction occurred after 125I particle stent treatment for hepatocellular carcinoma with portal vein tumor thrombus: A case report

  2024influential citation
• In silico and network pharmacology analysis of fucosterol: a potent anticancer bioactive compound against HCC

  2024cites this paper
• Age-dependent Female Survival Advantage in Hepatocellular Carcinoma: A Multicenter Cohort Study.

  2023cites this paper
• Comprehensive review of hepatocellular carcinoma with portal vein tumor thrombus: State of art and future perspectives.

  2023cites this paper
• Endovascular brachytherapy with iodine-125 seed strand for extensive portal vein tumor thrombus in patients with hepatocellular carcinoma

  2023cites this paper
• Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review

  2023cites this paper
• Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma

  2023cites this paper
• Breaking down tumor thrombus: Current strategies for medical management.

  2023cites this paper
• Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma

  2023cites this paper
• Role of nonneoplastic PVT in the natural history of patients with cirrhosis and first diagnosis of HCC

  2023cites this paper
• Hepatectomy versus transcatheter arterial chemoembolization for resectable BCLC stage A/B hepatocellular carcinoma beyond Milan criteria: A randomized clinical trial

  2023cites this paper
• Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study

  2022cites this paper
• Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of Cnidium monnieri in Treating Hepatocellular Carcinoma

  2022cites this paper
• Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis

  2022cites this paper
• Prognostic Influence of Spontaneous Tumor Rupture in Patients With Hepatocellular Carcinoma After Hepatectomy: A Meta-Analysis of Observational Studies

  2021cites this paper
• Integrated I-125 Seed Implantation Combined with Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombus

  2021cites this paper
• Estrogen Receptor 1 Inhibition of Wnt/β-Catenin Signaling Contributes to Sex Differences in Hepatocarcinogenesis

  2021cites this paper
• Clinicopathological and Prognostic Significance of Klotho and Estrogen Receptors Expression in Human Hepatocellular Carcinoma.

  2021cites this paper
• Portal Vein Irradiation Stent Plus Chemoembolization versus External Radiotherapy Plus Chemoembolization in Hepatocellular Carcinoma with Portal Vein Tumour Thrombus: A Retrospective Study

  2021cites this paper
• Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients

  2021cites this paper
• Development of Liver Cancers as an Unexpected Consequence of Anabolic Androgenic Steroid Use

  2021cites this paper
• YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior

  2021cites this paper
• Adaptation of lenvatinib treatment in patients with hepatocellular carcinoma and portal vein tumor thrombosis

  2021cites this paper
• Impact of Hepatectomy for Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombus

  2021cites this paper
• Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma

  2021cites this paper
• Sex disparity in hepatocellular carcinoma owing to NAFLD and non-NAFLD etiology: epidemiological findings and pathobiological mechanisms

  2020cites this paper
• Portal Vein Stenting Combined with 125I Particle Chain Implantation Followed by As2O3 in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumour Thrombus

  2020cites this paper
• Nomogram for Individualized Prediction of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis on Conservative Treatment

  2020cites this paper
• Preoperative Stereotactic Body Radiotherapy to Portal Vein Tumour Thrombus in Hepatocellular Carcinoma: Clinical and Pathological Analysis

  2020cites this paper
• Development of a prognostic gene signature for hepatocellular carcinoma.

  2020cites this paper
• Evaluation of doxorubicin-eluting bead transcatheter arterial chemoembolization combined with endovascular brachytherapy for hepatocellular carcinoma with main portal vein tumor thrombus

  2020cites this paper
• Early risk warning system for distant metastasis of hepatitis B virus-associated hepatocellular carcinoma with portal vein tumor thrombus

  2020cites this paper
• 18F-fluorodeoxyglucose PET/CT as an independent predictor for patients with hepatocellular carcinoma combined with major portal vein tumor thrombus

  2020cites this paper
• The Prediction of Survival in Hepatocellular Carcinoma Based on A Four Long Non-coding RNAs Expression Signature

  2020cites this paper
• Endovascular Treatment of Malignant Portomesenteric Venous Obstruction

  2020cites this paper
• Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT

  2020cites this paper
• Safety and Feasibility of Helical I-125 Seed Implants Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas with Main Portal Vein Tumor Thrombus

  2019cites this paper
• Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus

  2019cites this paper
• Hepatocellular carcinoma: Impact of academic setting and hospital volume on patient survival.

  2019cites this paper
• PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinoma

  2019cites this paper
• Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial.

  2019cites this paper
• Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity‐matched analysis of Surveillance, Epidemiology, and End Results database

  2019cites this paper
• The Role of Estrogen Receptors in Proliferation of Non-Small Cell Lung Cancer

  2018cites this paper
• Estrogen, estrogen receptors, and hepatocellular carcinoma: Are we there yet?

  2018cites this paper
• Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis

  2018cites this paper
• Two Nomograms to Select Hepatocellular Carcinoma Patients with Macroscopic Vascular Invasion for Hepatic Resection

  2018cites this paper
• Feasibility of Helical I-125 Seed Implant in the Portal Vein

  2018cites this paper
• Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha‐fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma

  2018cites this paper
• EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

  2018cites this paper
• Enhanced antitumor activity of combined megestrol acetate and arsenic trioxide treatment in liver cancer cells.

  2018cites this paper
• Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis

  2017cites this paper
• Sorafenib versus Hepatic Arterial Infusion Chemotherapy as Initial Treatment for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombosis

  2017cites this paper
• Change in the Treg/Th17 cell imbalance in hepatocellular carcinoma patients and its clinical value

  2017cites this paper
• Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study

  2017cites this paper
• Y-configuration stent combined with iodine-125 seeds strand for the treatment of hepatocellular carcinoma with tumor thrombosis in portal vein branches

  2017cites this paper
• Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

  2017cites this paper
• Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis

  2017cites this paper
• New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch

  2017cites this paper
• Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis

  2017cites this paper
• Clinical effects and safety of intra-arterial infusion therapy of cisplatin suspension in lipiodol combined with 5-fluorouracil versus sorafenib, for advanced hepatocellular carcinoma with macroscopic vascular invasion without extra-hepatic spread: A prospective cohort study.

  2017cites this paper
• Indication for surgical resection in patients with hepatocellular carcinoma with major vascular invasion.

  2017cites this paper
• Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients

  2017cites this paper
• Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil versus transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective analysis

  2017cites this paper
• Efficacy and safety of apatinib combined with transarterial chemoembolization for hepatocellular carcinoma with portal venous tumor thrombus: a retrospective study

  2017cites this paper
• Portal vein thrombosis: When to treat and how?

  2016cites this paper
• Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

  2016cites this paper
• Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma

  2016cites this paper
• Pathological complete response after percutaneous isolated hepatic perfusion in hepatocellular carcinoma with portal vein tumor thrombosis: a case report

  2016cites this paper
• Percutaneous Endovascular Radiofrequency Ablation for Malignant Portal Obstruction: An Initial Clinical Experience

  2016cites this paper
• Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma

  2016cites this paper
• [Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH].

  2016cites this paper
• Brachytherapy with Iodine-125 seeds strand for treatment of main portal vein tumor thrombi: an experimental study in a rabbit model.

  2016cites this paper
• Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study

  2016cites this paper
• Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis

  2016cites this paper
• Hepatocellular carcinoma

  2016cites this paper
• RETRACTED ARTICLE: In vitro derivation of mammalian germ cells from stem cells and their potential therapeutic application

  2015cites this paper
• Percutaneous implantation of 125iodine seeds for treatment of portal vein tumor thrombosis in hepatocellular carcinoma

  2015cites this paper
• Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization

  2015cites this paper
• Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study

  2015cites this paper
• A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis

  2015cites this paper
• Biology of Hepatocellular Carcinoma

  2015cites this paper
• Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib

  2015cites this paper
• Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma.

  2014cites this paper
• Role of estrogen in hepatocellular carcinoma: is inflammation the key?

  2014influential citation
• Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma

  2014cites this paper
• Preliminary experience of a new perspective view technology for the detection of portal vein thrombus in hepatocellular carcinoma patients

  2014cites this paper
• m-RECIST at 1 month and Child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinoma.

  2014cites this paper
• Impact of sex on the survival of patients with hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results analysis

  2014cites this paper
• Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: safety, efficacy, and prognostic factors.

  2014cites this paper
• Interventional treatment for unresectable hepatocellular carcinoma.

  2014cites this paper
• Methylation patterns of estrogen receptor α promoter correlate with estrogen receptor α expression and clinicopathological factors in hepatocellular carcinoma

  2014cites this paper
• Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma.

  2014cites this paper